FRANKLIN STREET ADVISORS INC /NC Supernus Pharmaceuticals, Inc. Transaction History

FRANKLIN STREET ADVISORS INC /NC portfolio value:

$677,000
portfolio value

FRANKLIN STREET ADVISORS INC /NC quarter portfolio value change:

+17.05%
quarter

Supernus Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 99K $33.85 20K
Q2 2022 share 0.00% 0 shares -68K $28.92 20K
Q1 2022 share Decrease -5.41% -1.14K shares 29K $32.32 20K
Q4 2021 share Decrease -47.33% -19K shares -454K $30.03 21.14K
Q3 2021 share Increase +81.28% 18K shares 389K $26.67 40.14K
Q2 2021 share Decrease -8.28% -2K shares 50K $30.79 22.14K
Q1 2021 share 0.00% 0 shares 25K $26.18 24.14K
Q4 2020 share 0.00% 0 shares 104K $25.16 24.14K
Q3 2020 share Decrease -15.71% -4.5K shares -177K $20.84 24.14K
Q2 2020 share 0.00% 0 shares 165K $23.75 28.64K
Q1 2020 share 0.00% 0 shares -164K $17.99 28.64K
Q4 2019 share 0.00% 0 shares -108K $23.72 28.64K
Q3 2019 share 0.00% 0 shares -161K $27.48 28.64K
Q2 2019 share 0.00% 0 shares -56K $33.09 28.64K
Q1 2019 share Decrease -0.19% -55 shares 51K $35.04 28.64K
Q4 2018 share Decrease -1.71% -500 shares -517K $33.22 28.7K
Q3 2018 share 0.00% 0 shares -278K $50.35 29.2K
Q2 2018 share 0.00% 0 shares 411K $59.85 29.2K
Q1 2018 share 0.00% 0 shares 173K $45.8 29.2K
Q4 2017 share Decrease -0.68% -200 shares -12K $39.85 29.2K
Q3 2017 share 0.00% 0 shares -91K $40 29.4K
Q2 2017 share Decrease -5.16% -1.6K shares 297K $43.1 29.4K
Q1 2017 share Decrease -66.67% -62K shares -1.37M $31.3 31K
Q4 2016 share 0.00% 0 shares 48K $25.25 93K
Q3 2016 share Decrease -12.57% -13.37K shares 133K $24.73 93K
Q2 2016 share Decrease -7.16% -8.2K shares 420K $20.37 106.37K
Q1 2016 share Decrease -8.08% -10.07K shares 72K $15.25 114.57K